Flushing. Long-term side effect of orchiectomy in treatment of prostatic carcinoma.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Urology

• Publication date

  1989-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0090-4295(89)90385-3PMID 2465644
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathophysiology of postmenopausal hot flushes

  1991cited by this paper
• A new hormonal therapy for prostatic cancer: long-term clinical and hormonal response.

  1986cited by this paper
• Measurement of skin blood‐flow and water evaporation as a means of objectively assessing hot flushes after orchidectomy in patients with prostatic cancer

  1985cited by this paper
• Androgen suppression by a gonadotropin releasing hormone analogue in patients with metastatic carcinoma of the prostate.

  1984cited by this paper
• Treatment of advanced prostatic cancer with buserelin, an analogue of gonadotrophin releasing hormone.

  1983cited by this paper
• Climacteric flushing in a man

  1983cited by this paper
• Compliance of patients and physicians: experience and lessons from tuberculosis.

  1983cited by this paper
• Climacteric flushing in a man.

  1983cited by this paper
• Prostatic cancer: treatment with long-acting LHRH analogue.

  1983cited by this paper
• Cyproterone acetate in treatment of post-orchidectomy hot flushes. Double-blind cross-over trial.

  1983cited by this paper
• The pathophysiology of postmenopausal hot flushes.

  1982cited by this paper
• Effects of total and subcapsular orchidectomy on serum concentrations of testosterone and pituitary hormones in patients with carcinoma of the prostate.

  1982cited by this paper
• The effects of orchidectomy, estrogens, and cyproterone acetate on plasma testosterone, LH, and FSH concentrations in patients with carcinoma of the prostate.

  1982cited by this paper
• Down‐regulation of gonadotrophin secretion in postmenopausal women by a superactive LHRH analogue: lack of effect on menopausal flushing

  1982cited by this paper
• Menopausal flushing: where now?

  1982cited by this paper
• Orchiectomy combined with cyproterone acetate or prednisone in the treatment of advanced prostatic carcinoma. A randomized clinical and endocrine study.

  1982cited by this paper
• Objective evidence that placebo and oral medroxyprogesterone acetate therapy diminish menopausal vasomotor flushes.

  1981cited by this paper
• Male climacteric after orchiectomy in patient with prostatic cancer.

  1980cited by this paper
• Physiological aspects of menopausal hot flush.

  1978cited by this paper
• Hot flushes after hypophysectomy.

  1977cited by this paper
• Menopausal flushing: does oestrogen therapy make sense?

  1976cited by this paper
• Subcapsular Orchidectomy—An Effective Operation?

  1976cited by this paper
• Subcapsular orchidectomy--an effective operation?

  1976cited by this paper
• Hot flashes and sweats in men with testicular insufficiency.

  1976cited by this paper
• Letter: Nomenclature of thyroid function tests.

  1973cited by this paper
• Plasma testosterone levels in patients with prostatic carcinoma before and after treatment.

  1968cited by this paper
• Carcinoma of the Prostate: Treatment Comparisons

  1967cited by this paper
• STUDIES ON PROSTATIC CANCER: II. THE EFFECTS OF CASTRATION ON ADVANCED CARCINOMA OF THE PROSTATE GLAND

  1941cited by this paper
• Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.

  1941cited by this paper
• Observations on Certain Parts of the Animal Economy, Inclusive of Several Papers from the Philosophical Transactions, &c.

  1839cited by this paper

• Improving actigraphy adherence among clinical trial participants with a real-time data-driven workflow

  2025cites this paper
• The Effect of Bilateral Orchiectomy on Total Prostate Specific Antigen (TPSA) Levels in Prostate Adenocarcinoma Patients

  2024cites this paper
• The Association Between Hot Flashes and Renal Dysfunction After Androgen Deprivation Therapy With Radiotherapy in Japanese Patients With High-risk Prostate Cancer

  2021cites this paper
• Complementary and alternative medicine for natural and treatment-induced vasomotor symptoms: An overview of systematic reviews and meta-analyses.

  2019cites this paper
• Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results from a single institution experience

  2018cites this paper
• Survivorship, Version 2.2019

  2018cites this paper
• Hyperhidrosis in palliative care patients

  2017cites this paper
• Many cancer survivors experience menopaus-NCCN Survivorship , Version 2 . 2017 Clinical Practice Guidelines in Oncology

  2017cites this paper
• A PROSPECTIVE STUDY TO EVALUATE THE EFFECTS OF SODIUM ALENDRONATE (AN ORAL BISPHOSPHONATE) ON BONE MINERAL DENSITY (BMD) IN PATIENTS WITH CARCINOMA PROSTATE TREATED WITH HORMONAL MANIPULATION

  2017cites this paper
• Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

  2017cites this paper
• A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients

  2015cites this paper
• Androgen deprivation therapy complications.

  2014cites this paper
• How long do the effects of acupuncture on hot flashes persist in cancer patients?

  2014cites this paper
• Dong Quai (angelica sinensis) in the treatment of hot flashes for men on androgen deprivation therapy: results of a randomized double-blind placebo controlled trial.

  2013cites this paper
• Management Options for Hot Flashes in Cancer Patients

  2013cites this paper
• Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer.

  2013cites this paper
• The efficacy of nonestrogenic therapy to hot flashes in cancer patients under hormone manipulation therapy: a systematic review and meta-analysis

  2013cites this paper
• Management of Newly Diagnosed Metastatic Disease

  2012cites this paper
• Evaluation of the Efficacy and Safety of Salvia officinalis in Controlling Hot Flashes in Prostate Cancer Patients Treated with Androgen Deprivation

  2012cites this paper
• The importance of supportive care in optimizing treatment outcomes of patients with advanced prostate cancer.

  2012cites this paper
• Mechanism of hot flashes

  2011cites this paper
• Nonestrogenic management of hot flashes.

  2011cites this paper
• 22 – Nonestrogenic management of hot flashes

  2011cites this paper
• Acupuncture treatment for hot flushes in women with breast cancer and men with prostate cancer

  2011cites this paper
• Prostate Carcinoma and Hot Flashes

  2011cites this paper
• Hot flashes: a review of pathophysiology and treatment modalities.

  2011cites this paper
• Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB.

  2010cites this paper
• Acupuncture for hot flashes in patients with prostate cancer.

  2010cites this paper
• Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.

  2010cites this paper
• Managing hot flushes in men after prostate cancer--a systematic review.

  2010cites this paper
• [Review of current treatment for hot flushes induced by androgen deprivation in prostate carcinoma].

  2009cites this paper
• Revisión del tratamiento actual de los sofocos inducidos por deprivación androgénica en el carcinoma prostático

  2009cites this paper
• Mecanismo fisiopatológico de los sofocos-sudores inducidos por deprivación androgénica en el carcinoma prostático

  2009cites this paper
• Auricular acupuncture: a novel treatment for vasomotor symptoms associated with luteinizing‐hormone releasing hormone agonist treatment for prostate cancer

  2009cites this paper
• Hot flashes during androgen deprivation therapy with luteinizing hormone-releasing hormone agonist combined with steroidal or nonsteroidal antiandrogen for prostate cancer.

  2009cites this paper
• [Physiopathological mechanism of hot flushes-perspiration induced by androgen deprivation in prostate carcinoma].

  2009cites this paper
• [Management of the side effects of androgenic deprivation].

  2008cites this paper
• [Development of a questionnaire to evaluate the impact of hot flashes in quality of life in patients with advanced prostate cancer. The ESCAPA study].

  2008cites this paper
• Evaluation of core and surface body temperatures, prevalence, onset, duration and severity of hot flashes in men after bilateral orchidectomy for prostate cancer.

  2008cites this paper
• Prise en charge des effets secondaires de l’hormonoprivation androgénique

  2008cites this paper
• A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB).

  2008cites this paper
• Desarrollo de un cuestionario sobre la repercusión de los sofocos en la calidad de vida de los pacientes con cáncer de próstata avanzado.: Estudio ESCAPA

  2008cites this paper
• Evaluation of Core and Surface Body Temperatures, Prevalence, Onset, Duration and Severity of Hot Flashes in Men after Bilateral Orchidectomy for Prostate Cancer EDITORIAL COMMENT

  2008cites this paper
• Gestion des effets secondaires de la suppression androgénique

  2008cites this paper
• Managing hot flashes in men being treated for prostate cancer.

  2007cites this paper
• Physiology and Endocrinology of Hot Flashes in Prostate Cancer

  2007cites this paper
• Androgen deprivation therapy: monitoring and managing the complications.

  2006cites this paper
• Managing complications of androgen deprivation therapy for prostate cancer.

  2006cites this paper
• Measuring hot flashes in men treated with hormone ablation therapy: an unmet need.

  2006cites this paper
• Hot flashes.

  2006cites this paper
• Pilot evaluation of selective serotonin reuptake inhibitor antidepressants in hot flash patients under androgen-deprivation therapy for prostate cancer

  2006cites this paper
• Mirtazapine: Hot Flashes

  2006cites this paper
• Acupuncture for hot flashes for prostate cancer patients.

  2005cites this paper
• Treatment of hot flushes in breast and prostate cancer

  2005cites this paper
• Periodic health examination, 1991 update: 3. Secondary prevention of prostate cancer

  2005cites this paper
• Climacteric-Like Disorders in Prostate Cancer Patients Treated With LHRH Agonists

  2005cites this paper
• Disorders of flushing

  2005cites this paper
• State of the science: hot flashes and cancer. Part 1: definition, scope, impact, physiology, and measurement.

  2005cites this paper
• Hot flash experience in men with prostate cancer: a concept analysis.

  2005cites this paper
• Parenteral medroxyprogesterone for the management of luteinizing hormone releasing hormone induced hot flashes in men with advanced prostate cancer.

  2005cites this paper
• Complications of androgen deprivation therapy: prevention and treatment.

  2004cites this paper
• Pilot evaluation of paroxetine for treating hot flashes in men.

  2004cites this paper
• [Selective serotonin reuptake inhibitors (SSRIs) antidepressants use in hot flashes in oncology].

  2004cites this paper
• Prevention by 17β-estradiol and progesterone of calcitonin gene-related peptide-induced elevation of skin temperature in castrated male rats

  2004cites this paper
• Place des antidépresseurs sérotoninergiques dans la prise en charge des bouffées de chaleur en cancérologie

  2004cites this paper
• Prevention by 17beta-estradiol and progesterone of calcitonin gene-related peptide-induced elevation of skin temperature in castrated male rats.

  2004cites this paper
• Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy

  2004cites this paper
• Complications of androgen-deprivation therapy for prostate cancer.

  2004cites this paper
• Andropause: symptom management for prostate cancer patients treated with hormonal ablation.

  2003cites this paper
• [Clinical evaluation of hot flushes developing during endocrine therapy for prostate carcinoma].

  2003cites this paper
• An eight-month clinical study of LA-2575 30.0 mg: a new 4-month, subcutaneous delivery system for leuprolide acetate in the treatment of prostate cancer.

  2003cites this paper
• A 12-month clinical study of LA-2585 (45.0 mg): a new 6-month subcutaneous delivery system for leuprolide acetate for the treatment of prostate cancer.

  2003cites this paper
• Complications of androgen deprivation therapy for prostate cancer

  2003cites this paper
• The Memorial Anxiety Scale for Prostate Cancer

  2003cites this paper
• Side effects of androgen deprivation therapy: monitoring and minimizing toxicity.

  2003cites this paper
• Incidence and management of hot flashes in prostate cancer.

  2003cites this paper
• Hot flushes in men: prevalence and possible mechanisms

  2002cites this paper
• Hot flushes and prostate cancer: pathogenesis and treatment

  2002cites this paper
• Fever and sweats in the patient with advanced cancer.

  2002cites this paper
• Depomedroxyprogesterone acetate for hot flashes.

  2002cites this paper
• Hormonersatztherapie bei Frauen nach Brustkrebserkrankung

  2002cites this paper
• Momentary increase in plasma calcitonin gene-related peptide is involved in hot flashes in men treated with castration for carcinoma of the prostate.

  2001cites this paper
• Venlafaxine: Hot Flashes

  2001cites this paper
• Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate.

  2001cites this paper
• Cancer of the Prostate

  2000cites this paper
• The evolving role of hormone therapy in advanced prostate cancer.

  2000cites this paper
• Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: a pilot study.

  1999cites this paper
• Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer.

  1999cites this paper
• Rehabilitation of prostate cancer.

  1999cites this paper
• Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors.

  1998cites this paper
• Rapid screening for psychologic distress in men with prostate carcinoma

  1998cites this paper
• Prevalence of Hot Flushes During and After Neoadjuvant Hormonal Therapy for Localized Prostate Cancer

  1998cites this paper
• Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancer

  1998cites this paper
• Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes

  1998cites this paper
• STRATEGIEN DER THERAPIE DER HITZEWALLUNGEN BEIM PROSTATAKARZINOMPATIENTEN UNTER HORMONABLATIVER THERAPIE

  1998cites this paper
• [The effective therapy of the hot flashes during hormone withdrawal treatment in patients with advanced prostatic carcinoma].

  1997cites this paper
• Bouffées de chaleur et traitement hormonal des cancers de la prostate

  1996cites this paper
• Les bouffées de chaleur de l'homme après castration

  1995cites this paper
• Hot flushes in men with pituitary adenoma.

  1995cites this paper
• Depot medroxyprogesterone in the management of benign prostatic hyperplasia.

  1995cites this paper